Internal Medicine, Gastroenterology · Bristol, CT
NPI
1447468954
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
25 Newell Rd, Suite E36
Bristol, CT, 06010
Phone (860) 583-9252
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
5,162 services
Medicare patients, 2024
290
Average age 73
Drug cost, 2024
$1.5M
1,894 prescriptions
Company payments, 2025
$1,625
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter E Bloom Jr. was code 99214 (office e&m - established), 96 times for 89 patients. In total Peter E Bloom Jr. billed 5,162 services in 36 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 96 | 89 | $90.77 | $8,714 |
| 99204 Office E&M - New | Office | 52 | 52 | $124.98 | $6,499 |
| 45385 Colonoscopy - Lesion Removal | Facility | 45 | 44 | $182.92 | $8,232 |
| 43239 Upper GI Endoscopy | Facility | 38 | 37 | $62.74 | $2,384 |
| 99203 Office E&M - New | Office | 32 | 32 | $69.32 | $2,218 |
| 99213 Office E&M - Established | Office | 22 | 22 | $61.59 | $1,355 |
| 99222 Hospital E&M - Initial | Facility | 22 | 21 | $102.44 | $2,254 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 11 | $97.36 | $1,752 |
| 99215 Office E&M - Established | Office | 17 | 16 | $146.19 | $2,485 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 11 | 11 | $189.82 | $2,088 |
By year: 2022 $94K for 3,911 services; 2023 $97K for 3,966 services; 2024 $105K for 5,162 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter E Bloom Jr. prescribed most often to Medicare patients was Omeprazole, with 353 prescriptions and refills. In total Peter E Bloom Jr. wrote 1,894 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 353 | 891 | 119 | $6,078 |
| Pantoprazole Sodium Generic | 149 | 400 | 53 | $1,947 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 130 | 130 | 128 | $7,946 |
| Famotidine Generic | 129 | 374 | 55 | $2,158 |
| Linzess Linaclotide | 96 | 230 | 36 | $127K |
| Metoclopramide Hcl Generic | 71 | 87 | 35 | $1,067 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 69 | 69 | 65 | $11K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 63 | 63 | 60 | $1,175 |
| Creon Lipase/Protease/Amylase | 50 | 65 | 16 | $176K |
| Ondansetron Odt Ondansetron | 49 | 59 | 28 | $1,778 |
| Dicyclomine Hcl Generic | 48 | 78 | 28 | $770 |
| Lansoprazole Generic | 47 | 127 | 13 | $1,419 |
| Sucralfate Generic | 42 | 69 | 15 | $4,552 |
| Colestipol Hcl Generic | 35 | 83 | 17 | $4,626 |
| Dexlansoprazole Dr Dexlansoprazole | 35 | 75 | Under 11 | $8,124 |
Brand drugs: - claims; generic drugs: 1,443 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter E Bloom Jr. $1,625 ($1,625 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $363.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $363 |
| Madrigal Pharmaceuticals MDGL | 4 | $223 |
| Lucid Diagnostics Inc. LUCD | 1 | $167 |
| Genzyme Corporation SNY | 7 | $164 |
| Janssen Biotech, Inc. JNJ | 5 | $106 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $96.58 |
| Intercept Pharmaceuticals, Inc. | 4 | $95.83 |
| Ardelyx, Inc. ARDX | 4 | $91.89 |
| Gilead Sciences, Inc. GILD | 4 | $81.08 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $65.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.